January 12, 2023 Comments Off on New patent for Pfizer drug IBRANCE Posted in: Patent Added Annual Drug Patent Expirations for IBRANCE Ibrance is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug IBRANCE appeared first on DrugPatentW…
January 11, 2023 Comments Off on New patent for Eli Lilly drug OLUMIANT Posted in: Patent Added Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug OLUMIANT appeared first on DrugPatentWatch – Ma…